MicroRNA-485-5p attenuates cell proliferation in glioma by directly targeting paired box 3

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-485-5p (miR-485-5p) is implicated in human cancers, but its function in glioma is not well understood.
• Glioma is a primary brain tumor with significant morbidity and mortality.
• Understanding the molecular mechanisms underlying glioma progression is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role of miR-485-5p in glioma development and progression.
• To identify the molecular targets and pathways regulated by miR-485-5p in glioma.
• To evaluate the therapeutic potential of miR-485-5p in glioma.

Main Methods:

• Analysis of miR-485-5p expression in glioma tissues and cell lines.
• In vitro and in vivo functional assays to assess the effect of miR-485-5p on glioma cell proliferation.
• Luciferase reporter assays and Western blotting to confirm the direct binding of miR-485-5p to PAX3 and its effect on protein expression.
• Investigation of downstream signaling pathways, including JNK phosphorylation.

Main Results:

• miR-485-5p was significantly downregulated in glioma tissues and cell lines.
• Overexpression of miR-485-5p suppressed glioma cell proliferation in vitro and in vivo and induced G1 cell cycle arrest.
• miR-485-5p directly targets the 3'-UTR of PAX3, reducing its protein expression.
• Decreased PAX3 expression led to p-JNK accumulation.
• Restoration of PAX3 expression rescued the inhibitory effects of miR-485-5p on glioma cell proliferation.

Conclusions:

• miR-485-5p acts as a tumor suppressor in glioma by inhibiting cell proliferation.
• The miR-485-5p/PAX3 axis plays a critical role in regulating glioma progression.
• miR-485-5p represents a promising novel therapeutic target for glioma treatment.